I don't believe there is a TO now Rynzn.
Dr Gittleson is on board to guide the PLATFORM strategy...medium term horizon.
The Boards job is to maximise shareholder value.
How do they do that?
By getting 3 or 4 non-DMD products into clinical development with Big Pharma.
Having said that ...Sarepta are desperate and have big hitter Funds on their register!
A cash + scrip offer may surprise - highly unlikely imo.
.
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-746
-
- There are more pages in this discussion • 351 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M |
Open | High | Low | Value | Volume |
8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 250808 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.9¢ | 312804 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 175000 | 0.088 |
5 | 1050954 | 0.087 |
4 | 45242 | 0.086 |
9 | 862962 | 0.085 |
5 | 239890 | 0.084 |
Price($) | Vol. | No. |
---|---|---|
0.089 | 312804 | 3 |
0.090 | 100000 | 1 |
0.095 | 55000 | 1 |
0.097 | 4356 | 1 |
0.098 | 76000 | 1 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |